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OBJECTIVE — In this randomized controlled trial we evaluated the effect of registered di-
etitian–led management of diabetes on glycemic control and macronutrient intake in type 2
diabetic patients in primary care clinics in Taiwan and studied the association between changes
in macronutrient intake and glycemic measures.
RESEARCH DESIGN AND METHODS — We recruited 154 adult patients with type 2
diabetes and randomly assigned them to a routine care control group (n  79) or a registered
dietitian–led intervention group (n  75) who received on-site diabetic self-management edu-
cation every 3 months over 12 months.
RESULTS — Over the 1-year period, neither the intervention group (n  75) nor the control
group (n  79) had signiﬁcant changes in A1C, whereas the intervention patients with poorly
controlled baseline A1C (7%) (n  56) had signiﬁcantly greater improvements in A1C and
fasting plasma glucose than the control subjects (n  60) (0.7 vs. 0.2%, P  0.034; 13.4
vs. 16.9 mg/dl, P  0.007) during the same period. We also found signiﬁcant net intervention-
control group differences in overall energy intake (229.06  309.16 vs. 56.10  309.41
kcal/day) and carbohydrate intake (31.24  61.53 vs. 7.15  54.09 g/day) (P  0.001) in
patients with poorly controlled A1C. Multivariable adjusted modeling revealed an independent
association between changes in carbohydrate intake and A1C in the intervention group (n  56;
0.10, SEM  0.033, P  0.004).
CONCLUSIONS — On-site registered dietitian–led management of diabetes can improve
glycemic control in patients with poorly managed type 2 diabetes in primary care clinics in
Taiwan. A reduction in carbohydrate intake may improve glycemic status.
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T
he World Health Organization has
predicted that the number of people
with diabetes will increase from 135
million in 1995 to 300 million by 2025
(1) with the greatest increases in Asia (2).
The annual incidence of diabetes is 0.5–
1.0% in Taiwan. There are at least
100,000 new cases per year (3) and
11.5% of total medical costs covered by
Taiwan’s national insurance is spent on
the treatment of diabetes and its compli-
cations (4).
The Diabetes Control and Complica-
tions Trial and UK Prospective Diabetes
Study (UKPDS) reported that the use of
multidisciplinary approaches with the
aimofmakinghealthychangesinlifestyle
can improve glycemic control and delay
or reduce further complications, some by
as much as 50–75% (5,6). Registered di-
etitians can contribute greatly to compre-
hensive care plans for diabetic patients,
who as a result of dietary education, have
been found to have improved anthropo-
metric measures and glycemic control
and use less prescribed medication (7,8).
In addition, patients with chronic dis-
eases, including diabetes, have been
found to beneﬁt from patient-centered
approaches encouraging self-manage-
ment of disease (9). Nevertheless, one
study in the U.S. reports that more than
half of the diabetic patients did not re-
ceivediabetic-relatedknowledgeandself-
managementskillsattheirprimaryclinics
and were not referred to relevant educa-
tional programs (10). In Taiwan, where
the number of on-staff registered dieti-
tians is determined by number of beds in
hospitals, primary care clinics are not re-
quired to have registered dietitians on
staff.
In this study, we hypothesized that
patients receiving ongoing patient-
centered consultation provided by a die-
titianwouldbemorelikelytofollowadiet
designed to improve glycemic control
than those not receiving such consulta-
tion. To ﬁnd out, we ﬁrst created a model
through which physicians, dietitians, and
nurses would cooperate to provide com-
prehensive individualized on-site patient
care and registered dietitian–led self-
management education. We then as-
sessed the effect of this program on
glycemic control and macronutrient in-
takes in 75 patients compared with 79
type 2 diabetic patients receiving the rou-
tine care practiced in their primary care
setting.
RESEARCH DESIGN AND
METHODS— To choose participat-
ing clinics, we visited the public health
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Taiwan, to obtain clinics known for their
careofdiabeticpatients.Theinvestigators
then visited clinics to ﬁnd out their will-
ingness to participate. Then, starting in
May2004,werecruited154patientswith
diagnosed or newly diagnosed type 2 di-
abetes aged between 30 and 70 years who
were receiving treatment at ﬁve primary
health care clinics. Type 2 diabetes was
diagnosed by primary physicians based
on criteria established by the American
DiabetesAssociation(ADA)(11).Patients
were excluded if they were pregnant or
undergoing dialysis or if they had re-
ceived an amputation or had comorbid
blindness, systemic illnesses such as can-
cer or cardiovascular disease based on
physician diagnosis of myocardial infarc-
tionorstrokeonnationalinsuranceclaim
forms. If the subjects were eligible and
willingtoparticipateinthisstudy,thepri-
mary physicians referred them to the reg-
istereddietitians.Theregistereddietitians
explained the study to the participants
and informed them that they would be
randomly assigned to either a registered
dietitian–led multidiscipline diabetes
management group (n  75) or a usual
care group (control group) (n  79).
Once a participant signed an informed
written consent form, he or she was en-
rolled in the study. The name, age, and
sex of the enrollees were entered into a
computer, which randomly assigned
them in a 1:1 manner to control groups
and intervention groups. The study pro-
tocol was approved by the institutional
review boards of National Health Re-
search Institutes/Taiwan and Kaohsiung
Medical University Hospital.
Intervention program
Patients in the control group received the
routine care practiced at their primary
care, which may have also included a
summary of basic dietary principles by
nurses.Patientsintheinterventiongroup,
in addition to receiving usual care, re-
ceived ongoing instruction on the self-
monitoring of glucose, medications,
exercise, hygiene (foot care), and compli-
cation management (11) from two
registereddietitianswhohadreceivedad-
ditional clinical training in the Depart-
ment of Endocrinology and Metabolism
and the Department of Nutrition at the
participatingmedicalcenter.Thepatients
in the intervention group were also pro-
videdindividualizednutritioncounseling
and dietary plans to reinforce the con-
cepts of controlling portion sizes of foods
every 3 months. During each visit, which
lasted 30–60 min, the registered dieti-
tians assessed patients’ understanding
and practice of dietary plans and self-care
skills and reinforced important knowl-
edge throughout the study period. The
physicians consulted with the registered
dietitians based on medicines prescribed
orpatients’self-carerelatedtoadjustment
of meal times and amount of food. The
registered dietitians were also provided
withahospital-usemobilephone.Thein-
tervention patient could call the regis-
tereddietitiansifheorsheneededdietary
advice,andtheregistereddietitianscalled
the patients to help solve problems that
patients might have encountered when
trying to follow the diet.
Nutrition education program
Duringeachinterventionpatientvisit,the
registered dietitians obtained daily nutri-
ent intake by asking the patients to recall
thefoodsconsumedfortheprevious24-h
period, a method of inquiry routinely
used in clinical settings in Taiwan. Nutri-
ent intake was analyzed by nutrient
analysis software (Nutrition Chamberlain
Line, Nutritionist Edition, Enhancement
version 2002, Ekitchen, Taichung, Tai-
wan). Each patient received dietary edu-
cation recommended by the ADA (12).
One goal was to avoid excessive energy
intake and assure balanced nutrition by
replacing high-fat with low-fat foods and
consuming foods rich in ﬁber and micro-
nutrients. A second goal was to introduce
the concept of portion size of the six food
groupstopatientsandemphasizethepos-
sible impact of portion size control, espe-
ciallycarbohydratecounting,onglycemic
control. Food models resembling stan-
dard portion sizes for food groups were
used to enhance the accuracy of diet-
related information. An individualized
dietplanwascreatedtomaintainintakeof
protein, fat, and carbohydrate energy to
15–20, 25–30, and 50–60%, respec-
tively, following the guidelines estab-
lished by the ADA (12).
Measurement of clinical parameters
At baseline and at 1 year, anthropometric
measurements and clinical laboratory
measurements after an 8- to 12-h fast
were obtained for both groups. In addi-
tion, both groups answered a registered
dietitian–administered questionnaire re-
garding demographic characteristics and
dietary habits. All clinical parameters
were sent to a laboratory (Protech Phar-
maservices, Taipei, Taiwan) certiﬁed by
The College of American Pathology and
U.S. Commission on Ofﬁce Laboratory
Accreditation. A1C assays were per-
formed using high-performance liquid
chromatography (Variant II; Bio-Rad,
Hercules, CA). Fasting plasma glucose,
cholesterol, triglyceride, LDL cholesterol,
HDL cholesterol, uric acid, creatinine,
and high-sensitivity C-reactive protein
were analyzed by enzymatic assay using
an autoanalyzer (Hitachi 7060; Hitachi,
Tokyo, Japan). Medical charts were re-
viewed to obtain information regarding
patient use of medications.
Statistical analysis
A t test was used to analyze differences
in continuous variables between two
groups. A 
2 test or Fisher exact test (if
n  5) was used to analyze distribution of
categorical variables. Simple linear re-
gression was used to examine the rela-
tions between changes in A1C and
changes in macronutrient intake (grams),
andmultiplelinearregressionwasusedto
adjust for confounders. All statistical
analyses were performed with SPSS (ver-
sion 11.5). P  0.05 was considered
signiﬁcant.
RESULTS— Eighteenpatientsdropped
out of the intervention group and 21 out
of the control group by the 1-year follow-
up, leaving us with 154 subjects. There
were no signiﬁcant group differences in
age, sex, disease duration, and education
in the 154 participants who remained
(Table 1). We also found no signiﬁcant
difference in age, sex, disease duration,
and education between the intervention
(n  56) and control (n  60) patients
withpoorbaselineglycemiccontrol(A1C
7%) (Table 2).
Clinical parameters
We found no signiﬁcant improvement in
A1C between the 75 intervention and 79
control patients regardless of baseline
A1C (Table 1), although we did ﬁnd a
signiﬁcant improvement in the fasting
plasma glucose intervention group com-
pared with the control subjects (P 
0.026) (Table 1). The 56 subjects in the
intervention group with poor baseline
glycemic control had a greater reduction
in mean A1C (0.7%) than the 60 control
subjects (0.2%) (P  0.034) as well as
signiﬁcantly greater improvements in
fasting plasma glucose (13.4  55.2
vs.16.9  63.6 mg/dl, P  0.007) and
systolic blood pressure (0.5  16.8 vs.
8.6  17.4 mmHg, P  0.012) (Table 2).
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ences in medication usage either at base-
line or at follow-up in patients with poor
baseline glycemic control (Table 2; sup-
plemental Table 1).
Dietary intake
In participants with A1C 7%, the inter-
vention group had a mean decrease in en-
ergy intake of 229  309.16 kcal/day,
whereas the control group had a mean in-
crease of 56.10  309.41 kcal/day (P 
0.001). Over the 12-month period, there
was a decrease in energy intake including
overall reduction in absolute amounts
(grams)ofcarbohydrates,fat,andproteinin
the intervention group (Table 3). Although
the energy percent values of carbohydrate,
fat,andproteinatbaselineandatthe1-year
intervention were similar for both groups,
the intervention group had signiﬁcantly
greater net reductions in saturated fat than
the control group (0.98  3.40 vs.
0.60  2.93, P  0.01) (Table 3). In ad-
dition, there was a signiﬁcant reduction in
energy (kilocalories per day) and fat (grams
per day) intake in those with A1C 7%
compared with that in control subjects
(data not shown).
Macronutrient intake and glycemic
control
Our univariate analysis showed a correla-
tion between changes in A1C and baseline
BMI, baseline A1C, and changes in energy
intake at per 100 kcal/day (0.200,
SEM  0.041, P  0.001) and carbohy-
drate intake at per 15 g/day (0.167,
SEM  0.029, P  0.001) in the interven-
tion group with baseline A1C 7% (Table
4).Afteradjustmentforage,sex,durationof
diabetes, baseline BMI, and baseline A1C,
we found an association between a 15-g in-
crease in carbohydrate (one carbohydrate
counting) intake and a 0.1% increase in
A1C (SEM  0.033, P  0.004) but not in
overall energy intake (0.04, SEM 
0.04, P  0.310) (Table 4).
CONCLUSIONS — This study showed
that the registered dietitian–led diabetes
managementprogramintheprimarycare
clinics signiﬁcantly improved the glyce-
mic control of type 2 diabetic patients
with baseline A1C 7%. We found a
strong and independent association be-
tween a reduction in carbohydrate intake
and improvements in A1C (P  0.001).
We observed a much greater reduction in
A1Cinourpoorlycontrolledintervention
group (0.7%) than in the control group
(0.2%) (P  0.034). Our intervention
group also had a 13.4 mg/dl reduction in
meanfastingglucoseplasma,whereasour
control group had a 16.9 mg/dl increase
in that measure (P  0.007).
Recently, some large randomized
controlled trials have also documented
the effectiveness of lifestyle or nutrition
interventions on delaying the progression
fromimpairedglucosetolerancetodiabe-
tesinhigh-riskindividuals(13,14).How-
ever, most of those studies were based on
patients receiving care in academic or
medical centers with more departments
and greater capacity to provide individu-
alized nutrition counseling than primary
care clinics. Although there have been
studies on the management of diabetes in
primary care (15), none have studied the
effect of the kind of registered dietitian–
led management of diabetes on glycemic
and diet controls that was proposed in
this study.
The effects of diabetic self-manage-
ment education focusing on dietary or
lifestyle changes have been reported in
some trials in primary care settings
Table 1—Baseline characteristics and changes of clinical parameters in type 2 diabetic patients after receiving a 12-month intervention or
usual care (control)
Baseline Changes from baseline to 12 months
Intervention Control P value Intervention Control P value
n 75 79 75 79
Baseline characteristics
Age (years) 56.6  8.0 56.9  7.5 0.802 — — —
Diabetes duration (years) 4.8  4.4 4.8  4.5 0.996 — — —
Male sex (%) 29 (38.7) 38 (48.1) 0.238 — — —
Education
6 years primary school 45 (60.0) 59 (74.7) 0.052 — — —
	6 years primary school 30 (40.0) 20 (25.3) — — —
Clinical measurements
Height (cm) 159.1  8.3 161.1  8.2 0.141 0.1  1.2 0.1  1.0 0.872
BMI (kg/m
2) 25.7  3.2 27.0  4.7 0.044 0.1  1.2 0.2  1.5 0.733
Systolic blood pressure (mmHg) 131.8  19.8 134.9  17.4 0.304 0.7  15.8 6.0  18.9 0.019
Diastolic blood pressure (mmHg) 79.7  10.5 84.2  10.3 0.008 0.0  11.0 0.6  10.9 0.736
Glucose (mg/dl) 147.4  49.6 159.7  53.4 0.141 6.8  50.1 12.7  56.9 0.026
A1C (%) 8.0  1.5 8.4  1.8 0.212 0.5  1.1 0.1  1.5 0.101
Triglyceride (mg/dl) 145.4  90.2 164.6  122.9 0.272 3.8  69.2 0.3  110.8 0.818
Total cholesterol (mg/dl) 183.0  37.9 187.3  38.4 0.488 5.1  39.3 0.3  43.7 0.424
HDL cholesterol (mg/dl) 50.1  12.2 48.7  11.1 0.471 0.1  11.2 0.6  8.7 0.743
LDL cholesterol (mg/dl) 117.8  33.4 118.5  32.5 0.898 6.0  35.9 0.1  36.3 0.297
GPT (units/l) 35.3  26.5 40.1  35.9 0.350 2.9  44.6 0.3  25.0 0.582
Creatinine (mg/dl) 0.8  0.3 0.8  0.2 0.631 0.0  0.4 0.0  0.2 0.765
Uric acid (mg/dl) 5.5  1.6 5.6  1.9 0.670 0.5  1.3 0.2  1.7 0.235
hs-CRP (mg/dl) 0.4  1.3 0.3  0.3 0.693 0.1  1.5 0.1  0.4 0.790
Data are means  SD or n (%). A t test or 
2 test was used to test differences between the intervention and control subjects at baseline. A t test was also used to
determinethechangesinclinicalparametersbetweenthetwogroupsaftera1-yearintervention.P0.05isconsideredsigniﬁcantlydifferent.GPT,glutamicpyruvic
transanimase; hs-CRP, high-sensitivity C-reactive protein.
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showed the intervention groups to have
greater reductions in A1C (0.92 to
1.8%) than the control groups (0.16
to0.4%).InoneFrenchstudyusingthe
Staged Diabetes Management Program
(18) in a primary care setting, the inter-
vention group had a 0.31% decrease in
A1C, whereas the control group had a
0.56% increase, which made an overall
difference of 0.86%. The intervention
group in this study had improvements
comparable in magnitude to those re-
portedbyothertrials(16–18)aswellasto
those reported by the UKPDS study,
which reported a 1% decrease in A1C for
the invention group and a 0.1% increase
in the control group (6). Another study of
a French population also demonstrated
that by introducing a diabetic manage-
ment program, glycemic control can be
improved without increasing the total
health care cost (18).
In this study, we tried to identify how
on-site nutrition counseling would affect
not only glycemic control but also adher-
ence with dietary recommendations and
self-management of disease in a primary
care setting. Although this study showed
no differences in A1C when the two
Table 2—Baseline characteristics and changes of clinical parameters and medication in type 2 diabetic patients with baseline A1C >7% after
receiving a 12-month intervention or usual care (control)
Baseline Changes from baseline to 12 months
Intervention Control P value Intervention Control P value
n 56 60 56 60
Baseline characteristics
Age (years) 55.8  8.2 57.4  7.5 0.286 — — —
Diabetes duration (years) 5.2  4.5 5.5  4.7 0.665 — — —
Male sex (%) 23 (41.1) 31 (51.7) 0.253 — — —
Education
6 year primary school 34 (60.7) 45 (75.0) 0.099 — — —
	6 year primary school 22 (39.3) 15 (25.0) — — —
Medication use
Glucose-lowering treatment
Sulfonylurea 54 (96.4) 57 (95.0) 1.000 — — —
Biguanide 45 (80.4) 50 (83.3) 0.677 — — —
Thiazolidinedione 7 (12.5) 14 (23.3) 0.130 — — —
Other oral hypoglycemia agent 0 (0.0) 2 (3.3) 0.496 — — —
Lipid-lowing treatment
Gemﬁbrozil 2 (3.6) 0 (0.0) 0.231 — — —
Statins 21 (37.5) 13 (21.7) 0.061 — — —
Fibrate 0 (0.0) 1 (1.7) 1.000 — — —
Antihypertensive treatment
Diuretics 1 (1.8) 2 (3.3) 1.000 — — —
-Blocker 0 (0.0) 2 (3.3) 0.496 — — —

-Blocker 1 (1.8) 1 (1.7) 1.000 — — —
Calcium-channel blocker 17 (30.4) 20 (33.3) 0.731 — — —
ACE inhibitor 7 (12.5) 9 (15.0) 0.696 — — —
Angiotensin receptor blocker 4 (7.1) 7 (11.7) 0.531 — — —
Aspirins 4 (7.1) 8 (13.3) 0.365 — — —
Clinical measurements
Height (cm) 159.3  8.2 161.2  8.4 0.206 0.1  1.3 0.2  1.0 0.769
BMI (kg/m
2) 25.7  3.2 26.8  4.2 0.093 0.2  1.3 0.2  1.3 0.953
Systolic blood pressure (mmHg) 132.4  20.9 134.3  18.9 0.627 0.5  16.8 8.6  17.4 0.012
Diastolic blood pressure (mmHg) 80.1  10.5 84.2  10.4 0.038 0.6  11.5 0.4  10.0 0.945
Glucose (mg/dl) 160.8  49.6 173.7  52.7 0.178 13.4  55.2 16.9  63.6 0.007
A1C (%) 8.6  1.2 9.0  1.5 0.087 0.7  1.1 0.2  1.7 0.034
Triglyceride (mg/dl) 157.9  97.7 161.8  126.2 0.856 9.7  67.9 3.6  111.8 0.445
Total cholesterol (mg/dl) 183.8  38.1 191.5  39.4 0.290 5.8  38.9 0.3  44.7 0.485
HDL cholesterol (mg/dl) 48.4  10.7 47.8  11.2 0.778 0.6  10.6 0.0  8.1 0.734
LDL cholesterol (mg/dl) 119.5  32.0 123.5  32.3 0.500 7.3  35.1 1.9  37.2 0.430
GPT (units/l) 37.6  27.5 38.8  34.5 0.840 2.8  18.1 0.0  22.9 0.468
Creatinine(mg/dl) 0.8  0.3 0.8  0.2 0.662 0.0  0.4 0.0  0.2 0.883
Uric acid(mg/dl) 5.5  1.6 5.6  2.1 0.819 0.5  1.3 0.3  1.8 0.451
hs-CRP (mg/dl) 0.5  1.5 0.3  0.3 0.540 0.1  1.8 0.1  0.3 0.908
DataaremeansSDorn(%).Attestor
2test(Fishertestwasusedasn5)wasusedtotestdifferencesbetweentheinterventionandcontrolsubjectsatbaseline.
Attestwasalsousedtodeterminethechangesinclinicalparametersbetweenthetwogroupsaftera1-yearintervention.P0.05isconsideredsigniﬁcantlydifferent.
GPT, glutamic pyruvic transanimase; hs-CRP, high-sensitivity C-reactive protein.
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should be noted that in our study the pa-
tients in the intervention group with fair
baseline A1C (7%) had signiﬁcantly
greater reductions in fasting plasma glu-
coseandintakeofenergy(kilocaloriesper
day) and fat (grams per day), but not in
overall change in A1C, compared with
control subjects. This ﬁnding provides
valuable information for future diabetes
care.
Imparting knowledge about nutrition
to patients is essential when one is teach-
ing diabetic patients how to self-manage
their diseases (11). Previous studies ana-
lyzing data by the India Health Service
Diabetes Care and Outcome Audit of
7,490 medical charts showed that pa-
tients receiving clinical nutrition educa-
tion from a registered dietitian or a
registered dietitian along with another
staff member had greater improvements
in A1C levels (0.26 and 0.32%, re-
spectively) than those receiving nutrition
education from either a non–registered
dietitian staff member or no nutrition ed-
ucation (0.19 and 0.10%, respec-
tively) (19). Furthermore, one study
entitled the Improving Control with Ac-
tivity and Nutrition Study, which ran-
domly assigned obese type 2 diabetic
patients to a registered dietitian–led case
management group and a usual care
group,reportedthattheirregistereddieti-
tian–led case management group had
greater reductions in weight, waist, A1C,
and use of prescription medication than
the control subjects (20). To our knowl-
edge, the current study is the ﬁrst in
Taiwan to demonstrate that effective gly-
cemic control can be achieved by inter-
ventions by registered dietitians
providing both diabetic self-management
education and intensive dietary counsel-
ing in a primary care setting. After 1 year,
energy intake had decreased by 229 
309.16kcal/dayintheinterventiongroup
but increased by 56.10  309.41 kcal/
day in the control group with A1C 7%.
We also found concomitant reductions in
theintakeofabsoluteamountsofallthree
macronutrients in our intervention
group. However, despite the signiﬁcant
reduction in total energy intake, we did
not ﬁnd signiﬁcant reductions in body
weight in the intervention group. The
lack of weight loss in the intervention
group might have occurred because
mostdiabeticpatientsweretakingasul-
fonylurea drug, which stimulates stor-
age of glycogen and lipogenesis. It has
been well documented that the use of
Table 4 —Univariate and multivariate regression analysis of factors associated with changes
of A1C in intervention subjects with baseline A1C >7% after receiving a 12-month
intervention
Simple linear regression Multiple linear regression
 (SEM) P value  (SEM) P value
Age (years) 0.031 (0.018) 0.096 0.013 (0.12) 0.304
Sex 0.252 (0.304) 0.411 0.367 (0.205) 0.080
Duration of diabetes (years) 0.016 (0.033) 0.641 0.027 (0.023) 0.232
Baseline BMI 0.104 (0.045) 0.026 0.042 (0.032) 0.200
Baseline A1C (%) 0.606 (0.093) 0.001 0.454 (0.084) 0.001
Change in energy intake
(100 kcal/day) 0.200 (0.041) 0.001 0.045 (0.043) 0.303
Change in carbohydrate intake
(15 g/day) 0.167 (0.029) 0.001 0.100 (0.033) 0.004
Change in fat intake
(15 g/day) 0.002 (0.124) 0.988 — —
Change in protein intake
(15 g/day) 0.188 (0.118) 0.117 — —
n  56.
Table 3—Changes in nutrient intakes in type 2 diabetic patients with baseline A1C >7% after receiving a 12-month intervention or usual care
(control)
Nutrient intakes
Baseline Changes from baseline to 12 months
Intervention Control P value Intervention Control P value
56 54 56 54
Energy (kcal/day) 1,899.0  399.8 1,877.5  405.3 0.778 229.06  309.16 56.10  309.41 0.001
Carbohydrates
Energy % 54.4  7.9 54.4  8.5 0.999 0.01  9.29 1.01  7.64 0.530
g/day 256.4  58.8 245.0  45.1 0.250 31.24  61.53 7.15  54.09 0.001
Protein
Energy % 14.9  2.8 14.8  3.5 0.786 0.52  3.60 0.12  3.50 0.345
g/day 70.4  18.3 68.4  24.6 0.622 10.91  18.85 2.94  18.60 0.001
Fat
Energy % 30.6  6.7 30.8  6.9 0.899 0.51  7.92 0.89  7.20 0.793
g/day 64.8  21.0 63.3  22.4 0.712 7.74  18.36 3.84  19.99 0.002
Monounsaturates (%) 9.7  3.0 10.0  3.7 0.686 0.61  3.91 1.00  3.70 0.596
Polyunsaturates (%) 10.9  3.0 11.0  3.7 0.852 0.05  4.47 0.65  4.83 0.500
Saturates (%) 8.7  3.1 7.8  2.9 0.141 0.98  3.40 0.60  2.93 0.010
Cholesterol (mg/day) 237.3  176.7 234.6  178.9 0.935 3.59  200.15 14.97  223.45 0.647
Data are means  SD. A t test was used to test differences between the intervention and control subjects at baseline. A t test was also used to determine the changes
in nutrient intakes between the two groups after a 1-year intervention. There were four subjects with missing dietary data at 1-year follow-up in the control group
(n  54). P  0.05 is considered signiﬁcantly different.
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weight gain (6).
Most randomized controlled trials
evaluating the effectiveness of diabetes-
self management or lifestyle education
have reported improvements in clinical
indexes (5–6,16–18), but few have doc-
umented dietary changes (21,22). One
study (21) using lifestyle education in di-
abetic patients reported signiﬁcant differ-
ences in reductions in total fat (percent
energy,P0.001)andsaturatedfat(per-
cent energy, P  0.001) and nonsigniﬁ-
cant (P  0.13) decreases in the total
energy intake between their intervention
andcontrolgroups(215vs.144kcal/
day, respectively). Another randomized
controlled trial (22), evaluating the effect
of a weight reduction (including dietary
counseling) and exercise program on di-
abetes management in older overweight
patients, reported signiﬁcant net differ-
ences in total energy intakes over 3
months (control 210.9 kcal/day, inter-
vention 200.4 kcal/day, and net differ-
ence 411.3 kcal/day). However, these
studies did not examine simultaneous as-
sociation between changes in dietary
components and metabolic parameters.
Our study showed that energy intake was
decreased by 229  309.16 kcal/day in
the intervention subjects and increased
by56.10309.41kcal/dayinthecontrol
subjectswithA1C7%(P0.001)after
1 year. Signiﬁcant net differences were
also observed between the absolute
amounts (grams per day) of carbohy-
drate/fat/protein consumption in the
intervention group (31.24/7.74/
10.91) and the control group (7.15/
3.84/2.94). After adjustment for
confounders, independent associations
were found between changes in carbo-
hydrate intake and A1C, indicating that
carbohydrates may be the most impor-
tant among macronutrients in inﬂuenc-
ing changes in A1C. This ﬁnding is
consistent with the ﬁnding that the
amount of carbohydrates consumed is a
strong predictor of glycemic response
(23). Therefore, portion size control or
carbohydrate counting such as those
suggested by the ADA may remain a key
dietary strategy in achieving desirable
glycemic control. Registered dietitians
can play an important role in imparting
this knowledge to diabetic patients and
in helping them implement changes in
diet.
There are some limitations in the cur-
rent study. Twenty-four-hour dietary re-
call is commonly used in routine clinical
nutrition counseling to estimate the food
intake of patients in Taiwan. Although
24-h recall has been found to be con-
founded by recall bias (24), interviews of
patients by trained dietitians who are able
toretrievemoreaccuratedietaryinforma-
tion may attenuate such errors. In addi-
tion, because both groups were likely to
have recall bias, the rates of underreport-
ing are probably comparable. Second, we
did not analyze insulin sensitivity at base-
line and only began doing it after the
1-year follow-up (unpublished data).
Therefore, the present study did not re-
portchangesininsulinsensitivityafterin-
tervention was started.
In summary, we found that the regis-
tered dietitian–led diabetes management
program aimed to increase a diabetic pa-
tient’s knowledge of how to self-manage
his or her illness was an effective strategy
for controlling glycemic status and
improving dietary habits for patients
with poorly controlled type 2 diabetes.
Changes in carbohydrate intake were in-
dependently associated with improve-
ments in glycemic control, emphasizing
theneedforcarbohydratecountinginnu-
trition education programs for diabetic
patients.
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